MedPath

Ketorolac Tromethamine

Ketorolac Tromethamine Injection, USP

Approved
Approval ID

3b3ed392-c37b-4fbc-bf30-e6400a201acb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 1, 2019

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ketorolac tromethamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71205-116
Application NumberANDA204216
Product Classification
M
Marketing Category
C73584
G
Generic Name
ketorolac tromethamine
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateDecember 1, 2018
FDA Product Classification

INGREDIENTS (6)

sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
ketorolac tromethamineActive
Quantity: 30 mg in 1 mL
Code: 4EVE5946BQ
Classification: ACTIB
hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
alcoholInactive
Code: 3K9958V90M
Classification: IACT
waterInactive
Code: 059QF0KO0R
Classification: IACT
sodium hydroxideInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ketorolac Tromethamine - FDA Drug Approval Details